|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Current assets: | |||||||||
| Cash and cash equivalents | |||||||||
| Restricted cash | |||||||||
| Marketable securities | |||||||||
| Marketable securities, current | |||||||||
| Research and development prepaid expenses | |||||||||
| Other prepaid expenses and current assets | |||||||||
| Total current assets | |||||||||
| Restricted cash, non-current | |||||||||
| Marketable securities, non-current | |||||||||
| Property and equipment, net | |||||||||
| Intangible assets | |||||||||
| Operating lease right-of-use assets, net | |||||||||
| Other assets, non-current | |||||||||
| Total assets | |||||||||
| Liabilities and Stockholders' Equity | |||||||||
| Current liabilities: | |||||||||
| Accounts payable | |||||||||
| Research and development accrued expenses | |||||||||
| Other accrued expenses and current liabilities | |||||||||
| Deferred revenue, current | |||||||||
| Operating lease liabilities, current | |||||||||
| Total current liabilities | |||||||||
| Operating lease liabilities, non-current | |||||||||
| Deferred tax liability | |||||||||
| Share repurchase liability | |||||||||
| Deferred revenue, non-current | |||||||||
| Other liabilities, non-current | |||||||||
| Total liabilities | |||||||||
| Redeemable convertible preferred stock, $0.0001 par value; zero and 89,016,578 shares authorized as of December 31, 2024 and 2023, respectively; zero and 85,960,088 shares issued and outstanding as of December 31, 2024 and 2023, respectively; aggregate liquidation preference of zero and $370,540 as of December 31, 2024 and 2023, respectively | |||||||||
| Stockholders' equity: | |||||||||
| Common Stock | |||||||||
| Voting common stock | |||||||||
| Non-voting common stock | |||||||||
| Total common Stock | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated other comprehensive income (loss) | |||||||||
| Accumulated deficit | |||||||||
| Total stockholders' equity | |||||||||
| Total liabilities and stockholders' equity |
Loading...
